Literature DB >> 9056563

Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.

J Hyett1, G Moscoso, K Nicolaides.   

Abstract

Pathological examination of the heart and great arteries was performed in 112 chromosomally abnormal fetuses after surgical termination of pregnancy at 11-16 weeks of gestation. The chromosomal abnormalities were diagnosed by chorion villus sampling which was carried out because screening of the pregnancies by a combination of maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation identified them as being at increased risk. The group consisted of 60 fetuses with trisomy 21, 29 with trisomy 18, 17 with trisomy 13 and 6 with Ullrich-Turner syndrome. The most common cardiac lesion seen in trisomy 21 fetuses was an atrioventricular or ventricular septal defect. Trisomy 18 was associated with ventricular septal defects and/or polyvalvular abnormalities. In trisomy 13, there were atrioventricular or ventricular septal defects, valvular abnormalities, and either narrowing of the isthmus or truncus arteriosus. Ullrich-Turner syndrome was associated with severe narrowing of the whole aortic arch. In all four groups of chromosomally abnormal fetuses, the aortic isthmus was significantly narrower than in normal fetuses and the degree of narrowing was significantly greater in fetuses with high nuchal translucency thickness. It is postulated that narrowing of the aortic isthmus may be the basis of increased nuchal translucency thickness in all four chromosomal abnormalities.

Entities:  

Mesh:

Year:  1997        PMID: 9056563     DOI: 10.1002/(sici)1096-8628(19970317)69:2<207::aid-ajmg18>3.0.co;2-p

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.

Authors:  Alessandro Sacco; Claudio Coco; Lucia Mangiafico; Pietro Cignini; Alessandra Tiezzi; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2007-10

2.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

Authors:  J Hyett; M Perdu; G Sharland; R Snijders; K H Nicolaides
Journal:  BMJ       Date:  1999-01-09

Review 3.  First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome.

Authors:  S Shiefa; M Amargandhi; J Bhupendra; S Moulali; T Kristine
Journal:  Indian J Clin Biochem       Date:  2012-10-12

4.  Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot.

Authors:  J M Meijer; P G Pieper; W Drenthen; A A Voors; J W Roos-Hesselink; A P J van Dijk; B J M Mulder; T Ebels; D J van Veldhuisen
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

5.  Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study.

Authors:  C Tennstedt; R Chaoui; H Körner; M Dietel
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

6.  Fetal echocardiography in trisomy 18.

Authors:  D Moyano; I C Huggon; L D Allan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-24       Impact factor: 5.747

Review 7.  The impact of fetal echocardiography.

Authors:  J P Kovalchin; N H Silverman
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

8.  Molecular signatures of cardiac defects in Down syndrome lymphoblastoid cell lines suggest altered ciliome and Hedgehog pathways.

Authors:  Clémentine Ripoll; Isabelle Rivals; Emilie Ait Yahya-Graison; Luce Dauphinot; Evelyne Paly; Clothilde Mircher; Aimé Ravel; Yann Grattau; Henri Bléhaut; André Mégarbane; Guy Dembour; Bénédicte de Fréminville; Renaud Touraine; Nicole Créau; Marie Claude Potier; Jean Maurice Delabar
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

9.  A logistic model to predict early pregnancy loss following in vitro fertilization based on 2601 infertility patients.

Authors:  Yan Yi; Guangxiu Lu; Yan Ouyang; Ge lin; Fei Gong; Xihong Li
Journal:  Reprod Biol Endocrinol       Date:  2016-03-31       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.